Clin2
NCT07039526Possibly a fitRecruiting

Cytalux for finding cancer during surgery

Esophageal CancerGastrointestinal CancersGynecologic Cancers

Part of Cancer, Digestive system clinical trials.

This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have cancer in your digestive system, pancreas, liver, bile ducts, esophagus, or a gynecologic cancer that needs a special type of surgery called HIPEC or debulking.
  • You are scheduled for surgery to remove a tumor or to look at how far the cancer has spread using a camera in your belly.
  • You agree to stop taking folic acid, folate, or any supplements with folate for 2 days before getting the study dye.
  • You or your legal guardian can sign a consent form to join the study.
  • You do not have a history of severe allergic reactions to indocyanine green or any part of the study dye.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07124351Recruiting· Phase 4
Using a special dye to see cancer during surgery

This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.

Los Angeles, California
NCT04734821Recruiting
Fluorescent imaging during stomach or esophagus surgery

This study tests whether a special fluorescent camera during surgery can help surgeons better operate on resectable (removable) stomach or esophagus cancer. It may help improve how surgery is guided, with the goal of safer and more accurate tumor removal.

Strasbourg
NCT07469202Not yet recruiting· Phase 4
Extra dose of imaging agent for lung and ovarian cancer surgery

This study tests an extra dose of a special imaging agent called CYTALUX that helps surgeons see cancer cells during surgery. It is given to people with lung or ovarian cancer to help make sure all the cancer is removed.

NCT07278986Recruiting· Early Phase 1
Imaging dye during endometrial cancer surgery

This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.

Philadelphia, Pennsylvania
NCT06511037Recruiting· Early Phase 1
Dye injection to help see cancer during belly surgery

This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.

Orange, California
NCT06235125Recruiting· Phase 1
Using Cytalux during lung surgery in children and teens

This study tests whether a dye called Cytalux, injected before lung surgery, can help surgeons see and remove cancer spots in children and teens with certain cancers. It may help make sure all visible cancer is removed during the operation.

Chicago, Illinois

Hear when a new Esophageal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.